Elanco Animal Health (ELAN) Profit After Tax (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Profit After Tax came in at $54.0 million in Q2 2026, up 390.91% year-over-year from $11.0 million in Q2 2025, and up 158.7% quarter-over-quarter from -$92.0 million in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Profit After Tax (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Profit After Tax across 10 years of filings, most recently posting $54.0 million for Q2 2026.
- In Q2 2026, Profit After Tax rose 390.91% year-over-year to $54.0 million; the TTM figure through Jun 2026 stood at -$348.0 million (down 162.7% YoY), while the FY2025 annual figure was -$232.0 million, down 168.64% from the prior year.
- Profit After Tax came in at $54.0 million for Q2 2026 at Elanco Animal Health, up from -$92.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $364.0 million in Q3 2024 to a low of -$1.1 billion in Q3 2023.
- Average Profit After Tax over 5 years is -$101.7 million, with a median of -$59.5 million recorded in 2022.
- Year-over-year, Profit After Tax plunged 3350.0% in 2025 and jumped 390.91% in 2026.
- Over 5 years, Profit After Tax stood at -$54.0 million in 2022, then plunged by 161.11% to -$141.0 million in 2023, then jumped by 94.33% to -$8.0 million in 2024, then sank by 3350.0% to -$276.0 million in 2025, then jumped by 119.57% to $54.0 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $54.0 million in Q2 2026, -$92.0 million in Q1 2026, and -$276.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 338.41 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 866.00 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 54.00 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 21.71 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | 1.83 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -241,611.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.00 Mn |
| Mar 31, 2026 | -92.00 Mn |
| Dec 31, 2025 | -276.00 Mn |
| Sep 30, 2025 | -34.00 Mn |
| Jun 30, 2025 | 11.00 Mn |
| Mar 31, 2025 | 188.00 Mn |
| Dec 31, 2024 | -8.00 Mn |
| Sep 30, 2024 | 364.00 Mn |
| Jun 30, 2024 | -77.00 Mn |
| Mar 31, 2024 | -199.00 Mn |
| Dec 31, 2023 | -141.00 Mn |
| Sep 30, 2023 | -1.10 Bn |
| Jun 30, 2023 | -97.00 Mn |
| Mar 31, 2023 | 103.00 Mn |
| Dec 31, 2022 | -54.00 Mn |
| Sep 30, 2022 | -65.00 Mn |
| Jun 30, 2022 | -463.00 Mn |
| Mar 31, 2022 | 51.00 Mn |
| Dec 31, 2021 | -105.00 Mn |
| Sep 30, 2021 | -108.00 Mn |